Life sciences companies are quickly integrating artificial intelligence into their work, but guardrails for using the ...

The campaign we have all just gone through has not been very focused on a lot of policy detail," said Buchanan Ingersoll & ...

A cell therapy developer with operations at the Philadelphia Navy Yard plans reduce its headcount by 33% next year as it ...

Watertown, Mass., added millions of square feet of lab space in just a few years. Here's how it happened, and why the pace ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

Dr. Verena Kallhoff serves as Sr. Director, Global Life Sciences at the Greater Houston Partnership. She works together with ...

In a report released yesterday, Madison Elsaadi from B.Riley Financial reiterated a Buy rating on Wave Life Sciences (WVE – Research ...

Vance Street, based in Los Angeles, is a middle market private equity firm that invests in several sectors, including medical technology and life science. The firm typically pursues companies with ...

The U.S. life sciences development bubble burst at the start of 2024, and it is going to take some time simply to pick up the pieces. There are already signs of recovery for the new year, though.

McNamara’s extensive experience in scaling imaging and eClinical companies through organic growth and acquisition strategies ...

What is your favorite part about practicing life sciences law at McDermott? Clients come to us with difficult questions that require not just ...

Skyward Specialty Insurance Group, Inc.TM, a leader in the specialty property and casualty market, today announced the launch of its new Life Sciences liability coverage. The strategic addition to the ...